SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
正版DY
Lv2
1
200 积分
2022-08-01 加入
最近求助
最近应助
互助留言
Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review
2小时前
已完结
A Systematic Review of Novel Intravesical Approaches for the Treatment of Patients with Non-muscle-invasive Bladder Cancer
2小时前
已完结
Characterization of HER2Alterations in 23,321 NSCLC Cases and Real-World Therapeutic Pattern in Chinese HER2-Mutant NSCLC the CHAPTER Study
14天前
已关闭
Targeting HER2 in the treatment of non-small cell lung cancer
14天前
已完结
Characterization of HER2 Alterations in 23,321 NSCLC Cases and Real-world Therapeutic Pattern in Chinese HER2-Mutant NSCLC: the CHAPTER Study
14天前
已关闭
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study
2个月前
已完结
Correlations of TNM staging and lymph node metastasis of gastric cancer with MRI features and VEGF expression
3个月前
已完结
Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial
3个月前
已完结
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer
3个月前
已完结
Loss of HER2 after HER2-targeted treatment
3个月前
已完结
Combinatorial metabolic engineering and tolerance evolving of Escherichia coli for high production of 2'-fucosyllactose
2年前
已采纳
感谢
2小时前
感谢
2小时前
长时间无人应助【积分已退回】
13天前
未求助到【积分已退回】
14天前
感谢
14天前
感谢
2个月前
感谢
3个月前
感谢
3个月前
感谢
3个月前
感谢
3个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论